Live Breaking News & Updates on Tozinameran

Pfizer/BioNTech's Drug Predict to Reach Peak Sales in Two Years


Pfizer/BioNTech’s Drug Predict to Reach Peak Sales in Two Years
by Angela Mohan on 
April 16, 2021 at 3:32 PM
Tozinameran is forecast to have peak sales of $24.8bn in its second year on the market, which 20% more than Humira s peak sales of $20.5bn, indicating that Comirnaty could be the next top drug in peak sales, as per GlobalData.
Quentin Horgan MSc, Analyst for Drugs Database at GlobalData, comments: Humira has been the top drug by sales for nearly a decade, despite having been on the market for nearly 20 years and having lost its market exclusivity within the EU in 2018 and Japan in 2017.

Japan , Quentin-horgan-msc , Drugs-database , Tozinameran , Heumatoid-arthritis , Umira , Adalimumab , Comirnaty , Pfizer-biontech-s , Japan , Ovid-19-vaccine

Pamplin Media Group - Mass vaccination shelter opens at Oregon Convention Center


Mass vaccination shelter opens at Oregon Convention Center
January 20 2021
Health officials say 7,500 people a day can be vaccinated against COVID-19 when it is fully staffed.
A new mass COVID-19 vaccination site opened at the Oregon Convention Center in Portland on Wednesday, Jan. 20, with the combined forces of Kaiser Permanente, OHSU, Providence and Legacy Health.
Officials with each health care system held joint press conference to provide more details.
The mass vaccination center will ramp up to full capacity sometime next week when Providence, Legacy Health and OHSU arrive. But Kaiser Permanente began administering vaccines on Wednesday.
The vaccinations are free.

Oregon , United-states , Portland , Oregon-convention-center , Kaiser-permanente , Legacy-health , Oregon-national-guard , Oregon-convention-center-on , Oregon-health-authority , Oregon-state , Topics-health-medical-pharma , Socialtag-medical-specialties

UK approves Moderna vaccine for use, intensifying coronavirus fight

Read more about UK approves Moderna vaccine for use, intensifying coronavirus fight on Business Standard. However, supplies of the new jab are not expected to be available until the spring in a few weeks time as the UK has pre-ordered 7 million doses

United-kingdom , Oxford-astrazeneca , National-health-service , Business-standard , Medicine , Medical-research , Health-sciences , Health , Clinical-trials , Covid-19-vaccine , Moderna , Vaccine